Corporate Magazine 2012 - Boehringer Ingelheim

C. H. Boehringer Sohn AG & Co. KG, IngelheimCOMPARISON OF BALANCE SHEETS 2003 – 2012(in millions of EUR)Assets (as of December 31) 2003 2004 2005Intangible assets 242 267 233Tangible assets 2,767 2,712 2,900Financial assets 2,462 2,756 3,396Fixed assets 5,471 5,735 6,529Inventories 1,000 1,085 1,229Accounts receivable (incl. deferred charges and deferred taxes) 2,537 2,477 3,013Liquid funds 1,134 1,333 1,247Current assets (incl. deffered charges and deferred taxes) 4,671 4,895 5,489Total assets 10,142 10,630 12,018Liabilities and equity (as of December 31) 2003 2004 2005Shareholders‘ capital 178 178 178Reserves (incl. currency conversion difference) 3,139 3,297 2,940Net income 529 888 1,491Total equity 3,846 4,363 4,609Minority interests 188 193 216Group equity 4,034 4,556 4,825Negative difference from acquisition of companies 0 0 0Provisions (incl. deferred taxes) 3,963 4,172 4,958Liabilities (incl. deferred charges) 2,145 1,902 2,235Total liabilities (incl. deferred taxes and deferred charges) 6,108 6,074 7,193Total liabilities and equity 10,142 10,630 12,018Comparison of Balance sheets2003 — 2012Summary of selected financial data 2003 2004 2005Net sales 7,382 8,157 9,535Operating income 901 1,372 1,923Operating income as % of net sales 12.2 16.8 20.2Income after taxes 537 908 1,514Income after taxes as % of net sales 7.3 11.1 15.9Return on shareholders‘ equity (in %) 15.0 23.1 34.2Equity ratio (in %) 37.9 41.0 38.4Cash flow 1,059 1,430 2,069Financial funds 3,516 4,015 4,585Personnel costs 2,252 2,443 2,671Personnel costs as % of net sales 30.5 29.9 28.0Average number of employees 34,221 35,529 37,406Research and development costs 1,176 1,232 1,360R & D as % of net sales 15.9 15.1 14.3Investments in tangible assets 516 427 532Depreciation of tangible assets 354 377 439